Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Alla V Rudakova"'
Autor:
Alla V Rudakova, Vladimir V Strugov
Publikováno v:
Современная онкология, Vol 21, Iss 2, Pp 29-32 (2019)
Background. Current treatment of relapsed/refractory chronic lymphocytic leukemia implies the use of regimens that include innovative drugs such as ibrutinib and a combination of venetoclax with rituximab. Herewith the combination of venetoclax with
Externí odkaz:
https://doaj.org/article/3d924aa74df24ca49dc3939e6a60aa58
Autor:
Alexander A. Baranov, Alexander V. Plakida, Leyla S. Namazova-Baranova, Mikhail A. Semenov, Olga V. Ilyushina, Yevgeniy V. Guretskiy, Marina V. Fedoseenko, Alla V. Rudakova
Publikováno v:
Педиатрическая фармакология, Vol 16, Iss 2, Pp 101-110 (2019)
Background.The human papillomavirus (HPV) is one of the most common sexually transmitted viruses and, according to WHO, the cause of 7.5% of all women deaths from cancer. Every year, more than 500.000 new cases of HPV-associated cancer are registered
Externí odkaz:
https://doaj.org/article/4f0253a4e84c4bc7aab6d539b71dbe11
Autor:
Alexander A. Baranov, Leyla S. Namazova-Baranova, Nikolay I. Brico, Yurii V. Lobzin, Roman S. Коzlov, Mikhail P. Kostinov, Irina S. Koroleva, Alla V. Rudakova, Sergey V. Sidorenko, Vladimir K. Tatochenko, Susanna M. Kharit, Marina V. Fedoseenko, Elena A. Vishneva, Liliya R. Selimzyanova
Publikováno v:
Педиатрическая фармакология, Vol 15, Iss 3, Pp 200-211 (2018)
Pneumococcal infection remains one of the leading reasons for infant mortality from vaccine-preventable infections. Today vaccination is the most effective way to prevent diseases caused by antibiotic-resistant pneumococci. In the article, authors pr
Externí odkaz:
https://doaj.org/article/5054b6083eea4d1080813db5117b47b7
Autor:
Alla V. Rudakova, Susanna M. Kharit, Aleksandr T. Podkolzin, Aleksandr N. Uskov, Yurii V. Lobzin
Publikováno v:
Педиатрическая фармакология, Vol 14, Iss 6, Pp 501-507 (2018)
One of the main causes of the incidence of intestinal infections in children under 5 years infection is rotavirus. Vaccines against rotavirus infection substantially reduce morbidity.The objective of this study is to analyze cost-effectiveness of vac
Externí odkaz:
https://doaj.org/article/a7e92093ad9c45d8b79917f4d7b53df1
Autor:
Alla V. Rudakova, Susanna M. Kharit, Lyudmila V. Lyalina, Alla S. Lisianskaya, Svetlana A. Protsenko, Irina V. Mikheeva, Aleksandr N. Uskov, Yurii V. Lobzin
Publikováno v:
Педиатрическая фармакология, Vol 14, Iss 6, Pp 494-500 (2018)
The human papillomavirus (HPV) infection is one of the major risk factor of development of genital warts, a cervical dysplasia, a cervical cancer, and also some other oncologic diseases. The usage of quadrivalent HPV vaccine in girls reduces the corr
Externí odkaz:
https://doaj.org/article/b704cc23c71b4a88a1048be31421d63d
Autor:
Alexander T. Podkolzin, Alla V. Rudakova, Yury V. Lobzin, Nina V. Tikunova, Susanna M. Kharit, Michelle G. Goveia, Megan A. O’Brian, Boris M. Blokhin, Maria K. Bekhtereva
Publikováno v:
The Pediatric infectious disease journal. 36(5)
BACKGROUND This is a prospective, multicentered study conducted in 9 large urban areas in Russia, in order to determine the burden of rotavirus gastroenteritis in children
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9d75f8e008478d9ac67aee10dfe10e2a
https://pubmed.ncbi.nlm.nih.gov/27997518
https://pubmed.ncbi.nlm.nih.gov/27997518